Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Study protocol: To investigate effects of highly specialized rehabilitation for patients with multiple sclerosis a randomized controlled trial of a personalized, multidisciplinary intervention.
MMP-9 in Translation: From Molecule to Brain Physiology, Pathology and Therapy.
Complex assessment in progressive multiple sclerosis: a case report.
The effects of clinical interventions on health-related quality of life in multiple sclerosis: a meta-analysis.
Leg spasticity and ambulation in multiple sclerosis.
Downregulation of cystathionine β-synthase/hydrogen sulfide contributes to rotenone-induced microglia polarization toward M1 type.
Isolated Brain Stem Lesion in Children: Is It Acute Disseminated Encephalomyelitis or Not?
Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue: a cross-sectional study.
Management of faecal incontinence and constipation in adults with central neurological diseases.
Intractable and highly active relapsing multiple sclerosis - role of alemtuzumab.
Copy number variation in pediatric multiple sclerosis.
Antibodies Against Human BLyS and APRIL Attenuate EAE Development in Marmoset Monkeys.
The new therapeutic landscape in multiple sclerosis: exciting times and new perspectives.
Oral simvastatin treatment in relapsing-remitting multiple sclerosis.
Beneficial effects of UV radiation other than via vitamin D production.
Is walking capacity in subjects with multiple sclerosis primarily related to muscle oxidative capacity or maximal muscle strength? A pilot study.
Electrophysiological features of POEMS syndrome and chronic inflammatory demyelinating polyneuropathy.
[The process of meaning-making in adjustment to multiple sclerosis.]
Compromised motor imagery ability in individuals with multiple sclerosis and mild physical disability: An ERP study.
Vitamin D and multiple sclerosis: timing of sampling, treatment and prevention.
A machine learning pipeline for multiple sclerosis course detection from clinical scales and patient reported outcomes.
Pelizaeus-Merzbacher disease-associated proteolipid protein 1 inhibits oligodendrocyte precursor cell differentiation via extracellular-signal regulated kinase signaling.
Leuprolide Acetate, a GnRH Agonist, Improves Experimental Autoimmune Encephalomyelitis: A Possible Therapy for Multiple Sclerosis.
Long-term treatment risks in multiple sclerosis: risk knowledge and risk perception in a large cohort of mitoxantrone-treated patients.
Structure and inhibition of herpesvirus DNA packaging terminase nuclease domain.
Pages
« first
‹ previous
…
282
283
284
285
286
287
288
289
290
…
next ›
last »